American International Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,337
| Closed | -$37.6K | – | 3257 |
|
|
2023
Q1 | $37.6K | Buy |
20,337
+405
| +2% | +$502 | ﹤0.01% | 2785 |
|
|
2022
Q4 | $22.1K | Sell |
19,932
-72
| -0.4% | -$102 | ﹤0.01% | 2913 |
|
|
2022
Q3 | $47K | Buy |
20,004
+282
| +1% | +$999 | ﹤0.01% | 2831 |
|
|
2022
Q2 | $60K | Buy |
19,722
+3,355
| +20% | +$16.3K | ﹤0.01% | 2820 |
|
|
2022
Q1 | $111K | Sell |
16,367
-1,152
| -7% | -$8.21K | ﹤0.01% | 2555 |
|
|
2021
Q4 | $146K | Sell |
17,519
-524
| -3% | -$4.32K | ﹤0.01% | 2547 |
|
|
2021
Q3 | $134K | Sell |
18,043
-429
| -2% | -$2.66K | ﹤0.01% | 2660 |
|
|
2021
Q2 | $126 | Buy |
18,472
+8,415
| +84% | +$69.9K | ﹤0.01% | 2783 |
|
|
2021
Q1 | $103 | Buy |
10,057
+27
| +0.3% | +$296 | ﹤0.01% | 2707 |
|
|
2020
Q4 | $70 | Sell |
10,030
-288
| -3% | -$2.24K | ﹤0.01% | 2838 |
|
|
2020
Q3 | $84K | Sell |
10,318
-235
| -2% | -$1.46K | ﹤0.01% | 2623 |
|
|
2020
Q2 | $73K | Buy |
10,553
+975
| +10% | +$5.26K | ﹤0.01% | 2717 |
|
|
2020
Q1 | $45K | Sell |
9,578
-554
| -5% | -$3.19K | ﹤0.01% | 2728 |
|
|
2019
Q4 | $88K | Sell |
10,132
-84
| -0.8% | -$454 | ﹤0.01% | 2700 |
|
|
2019
Q3 | $34K | Sell |
10,216
-72
| -0.7% | -$288 | ﹤0.01% | 2969 |
|
|
2019
Q2 | $51K | Buy |
10,288
+234
| +2% | +$1.24K | ﹤0.01% | 2939 |
|
|
2019
Q1 | $62K | Sell |
10,054
-326
| -3% | -$1.57K | ﹤0.01% | 2807 |
|
|
2018
Q4 | $35K | Sell |
10,380
-80
| -0.8% | -$374 | ﹤0.01% | 2958 |
|
|
2018
Q3 | $68K | Buy |
10,460
+189
| +2% | +$1.41K | ﹤0.01% | 2987 |
|
|
2018
Q2 | $79K | Buy |
10,271
+1,018
| +11% | +$14.7K | ﹤0.01% | 2883 |
|
|
2018
Q1 | $207K | Sell |
9,253
-499
| -5% | -$11.1K | ﹤0.01% | 2246 |
|
|
2017
Q4 | $124K | Buy |
9,752
+193
| +2% | +$2.84K | ﹤0.01% | 2615 |
|
|
2017
Q3 | $149K | Buy |
9,559
+5,442
| +132% | +$76.9K | ﹤0.01% | 2450 |
|
|
2017
Q2 | $58K | Buy |
+4,117
| New | +$88.1K | ﹤0.01% | 2966 |
|
Other funds holding JNCE
American International Group's JNCE Position: Q2 2023 in Review
American International Group sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 20,337 shares — an estimated $37.6K sold.
American International Group first reported a position in JNCE in Q2 2017 and held it in 24 quarters. The position peaked at $207K in Q1 2018. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.
- American International Group reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- American International Group sold 20,337 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
- American International Group first reported a position in Jounce Therapeutics, Inc. Common Stock in Q2 2017 and held it in 24 quarters.
- American International Group's Jounce Therapeutics, Inc. Common Stock position peaked at $207K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.
Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.